Clinical study on the treatment of stage III - IV colorectal cancer of spleen deficiency and essence deficiency type with anticancer essence formula

onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•All of the following items are met:
•1. Patients with age >= 18 years and < 75 years old;
•2. Patients with stage III-IV colorectal cancer confirmed by pathology (see Table 1 for staging criteria), who did not receive targeted therapy and were 1-6 months after the end of chemotherapy;
•3. Patients with an estimated survival time of more than 3 months;
•4. Patients who have no tumor after radical operation;
•5. ECoG activity score was 0 or 1;
•6. Patients with spleen deficiency and essence deficiency syndrome.

•1. Patients with other malignant tumor history;
•2. Patients with severe cardiovascular and cerebrovascular diseases (such as stroke, myocardial infarction);
•3. Patients with severe liver and kidney dysfunction (liver enzymes > 3 times of normal upper limit or estimated glomerular filtration rate < 30ml / min);
•4. Patients who have received traditional Chinese medicine treatment within one month;
•5. Patients who have participated in or are participating in other clinical studies within three months;
•6. Pregnant or lactating women.

发起方

onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine